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Decoding Dopamine Signaling

dated.
There are several barriers to elucidating the signaling pathways elicited by binding of dopamine to its D2 Dopamine is a key neurotransmitter that is important receptor. The receptors are polymorphic and are not for many physiological functions including motor particularly abundant, and mono-specific antibodies control, mood, and the reward pathway. In this issue against D2 receptors have been difficult to obtain. D2 of Cell, the laboratories of Marc Caron and Li-Huei receptors are G protein-coupled receptors (GPCRs) Tsai identify two very different molecules-␤-arrestin containing the characteristic seven transmembrane re-2 and Par-4, respectively-that unexpectedly are ingions and three N-linked glycosylation sites (see Figure  volved in tase-1 (PP1), glycogen synthase kinase 3 (GSK3), the cAMP is produced. In contrast, when dopamine binds Raf/MEK/ERK1/2 pathway, phosphoinositol 3-kinase (PI to the Gαi/o-coupled D2, D3, and D4 receptors, adenyl-3-kinase), and transcription factors such as CREB, nuclear ate cyclase activity is blocked and cAMP production is factor-κB (NF-κB), and serum-responsive element (Misreduced ( et al., 2001 ). An emerging theme seems to be that components of the programmed cell death pathway are commandeered as mediators of neurotransmission and synaptic plasticity in the brain.
